We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$3.09B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$8.22B
AUM Growth
+$272M
(+3.4%)
Cap. Flow
-$981M
Cap. Flow
% of AUM
-11.94%
Top 10 Holdings %
Top 10 Hldgs %
21.98%
Holding
1,489
New
477
Increased
218
Reduced
244
Closed
468
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$57.9M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$52.4M |
| 3 |
ExxonMobil
XOM
|
+$49M |
| 4 |
Colgate-Palmolive
CL
|
+$45.4M |
| 5 |
CF Industries
CF
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$64.1M |
| 2 |
Meta Platforms (Facebook)
META
|
+$58.9M |
| 3 |
MON
Monsanto Co
MON
|
+$54.7M |
| 4 |
CELG
Celgene Corp
CELG
|
+$53.6M |
| 5 |
Target
TGT
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 9.92% |
| 2 | Healthcare | 9.35% |
| 3 | Technology | 6.84% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLT
551
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $798K | 0.01% |
+56,556
| New | +$687K |
|
|
TYC
552
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $798K | 0.01% |
+16,714
| New | +$753K |
|
|
QCOR
553
DELISTED
QUESTCOR PHARMA INC
QCOR
| $797K | 0.01% |
8,619
-40,965
| -83% | -$3.51M |
|
554
Geron
GERN
$828M
| $795K | 0.01% |
+262,012
| New | +$547K |
|
555
PUT
General Mills
GIS
$19.1B
| $793K | 0.01% |
15,100
-48,300
| -76% | -$2.58M |
|
|
RGC
556
DELISTED
Regal Entertainment Group
RGC
| $793K | 0.01% |
+37,583
| New | +$735K |
|
557
CALL
Hershey
HSY
$35.2B
| $789K | 0.01% |
8,100
-39,400
| -83% | -$3.86M |
|
558
CALL
Veeva Systems
VEEV
$33.1B
| $783K | 0.01% |
+30,800
| New | +$666K |
|
|
YELL
559
CALL
DELISTED
Yellow Corporation Common Stock
YELL
| $779K | 0.01% |
27,700
-3,900
| -12% | -$86.9K |
|
|
CIT
560
DELISTED
CIT Group Inc.
CIT
| $771K | 0.01% |
16,847
-43,470
| -72% | -$1.96M |
|
|
RTN
561
CALL
DELISTED
Raytheon Company
RTN
| $765K | 0.01% |
8,300
-10,800
| -57% | -$1.05M |
|
|
562
PUT
Veeva Systems
VEEV
$33.1B
| $764K | 0.01% |
+30,000
| New | +$649K |
|
|
IMGN
563
DELISTED
Immunogen Inc
IMGN
| $761K | 0.01% |
+64,190
| New | +$806K |
|
564
Lesaka Technologies
LSAK
$396M
| $754K | 0.01% |
66,235
+53,026
| +401% | +$548K |
|
565
RH
RH
$3.13B
| $754K | 0.01% |
+8,100
| New | +$567K |
|
566
PUT
Targa Resources
TRGP
$58B
| $754K | 0.01% |
+5,400
| New | +$621K |
|
567
PUT
Fair Isaac
FICO
$24.3B
| $753K | 0.01% |
11,800
-9,400
| -44% | -$537K |
|
|
XLNX
568
CALL
DELISTED
Xilinx Inc
XLNX
| $752K | 0.01% |
15,900
-11,300
| -42% | -$544K |
|
569
PUT
Amazon
AMZN
$2.92T
| $747K | 0.01% |
+46,000
| New | +$728K |
|
|
CAMP
570
CALL
DELISTED
CalAmp Corp.
CAMP
| $741K | 0.01% |
1,487
+17
| +1% | +$7.98K |
|
|
AWAY
571
PUT
DELISTED
HOMEAWAY INC COM
AWAY
| $739K | 0.01% |
+21,200
| New | +$697K |
|
|
ZIONW
572
DELISTED
Zions Bancorporation N.A. Warrants
ZIONW
| $734K | 0.01% |
139,540
+734
| +0.5% | +$4.1K |
|
573
Regional Management Corp
RM
$301M
| $733K | 0.01% |
+47,406
| New | +$814K |
|
574
CALL
Assured Guaranty
AGO
$3.66B
| $726K | 0.01% |
+29,600
| New | +$734K |
|
|
MDRX
575
DELISTED
Veradigm Inc. Common Stock
MDRX
| $725K | 0.01% |
+45,179
| New | +$704K |
|
Similar funds
DCM
CAM
VBA
MRCP
ECP
TCG
PC
CCI
Highbridge Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Highbridge Capital Management held 1,489 positions worth $8.22B, up 3.4% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Highbridge Capital Management withdrew a net $981M in Q2 2014, closing 468 positions and reducing 244 holdings. Its most notable exit was Celgene Corp, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 9.9% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Highbridge Capital Management opened a new position in Bausch Health worth $38.6M.
- Highbridge Capital Management's largest Q2 2014 buy was Bausch Health: 305,899 shares worth $38.6M.
- Highbridge Capital Management added most to Citigroup in Q2 2014, an estimated $57.9M increase.
- Highbridge Capital Management's biggest Q2 2014 reduction was Intel, cutting an estimated $64.1M.
- Highbridge Capital Management fully exited Celgene Corp in Q2 2014, selling an estimated $53.6M.
- Highbridge Capital Management's ten largest holdings make up 22% of its $8.22B portfolio in Q2 2014.
- Highbridge Capital Management opened 477 new positions and closed 468 in Q2 2014.
- Highbridge Capital Management's portfolio value rose 3.4% quarter-over-quarter to $8.22B.
Based on Highbridge Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.